SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

BBNX

Beta Bionics Inc.
NASDAQHealth Care

Latest close: 16.35 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 14, 2026Reported sale · Form 4Mark Hopman, Chief Commercial Officer · $13.4KOpen the filing ↗
  2. Oct 1, 2026Reported sale · Form 4Mark Hopman, Chief Commercial Officer · $7.0KOpen the filing ↗
  3. Oct 1, 2026Notice of sale · Form 144MARK HOPMAN · Officer · $50.5KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record24117 flagged findings
Reported transactions (Form 4)80since Jan 31, 2025 · and 21 other holdings
Corporate events (8-K)2since Jan 31, 2025

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-02-24share offering or dilution eventrecentOpen filing ↗
    “…• on or through the facilities of the Nasdaq Global Market or any other securities exchange or quotation or trading service on…”
  • 2026-02-24capital return (buybacks/dividends)recentOpen filing ↗
    “…provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐ Table of Contents PROSPECTUS Common Stock Preferred Stock Debt…”
    +1 more passage from the same document
    • “…dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate; • our right, if…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 241)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

241 filings on record, the oldest from Oct 10, 24.

Listing the 25 most recent filings of the 241 on record.

8-Ks, explained

Structure1Governance1
  • Mar 27, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jan 31, 25StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • T. Rowe Price Associates, Inc.16.6%Sep 30, 26SCHEDULE 13G ↗
  • Eventide Asset Management, LLC13.4%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Levy Guy9.8%Mar 31, 26SCHEDULE 13G/A ↗9 co-filers on this document — the figure is the largest single stake, not their sum.
  • Dapice Joshua J.8.1%Mar 31, 26SCHEDULE 13G/A ↗28 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Divisadero Street Capital Management, LP6.9%Jul 17, 26SCHEDULE 13G ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
show 5 more holdershide
  • BlackRock, Inc.6.4%Sep 30, 25SCHEDULE 13G ↗
  • Guy Levy5.8%Dec 31, 25SCHEDULE 13G/A ↗13 co-filers on this document — the figure is the largest single stake, not their sum.
  • Point72 Asset Management, L.P.5.2%Feb 18, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • RTW Investments, LP4.5%Mar 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Farallon Capital Management, L.L.C.1.3%Jun 30, 26SCHEDULE 13G/A ↗28 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Oct 1, MARK HOPMAN filed notice of intent to sell up to $50K. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $20K across 2 trades, between Oct 1 and Oct 14, per their Form 4. That is 43% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+9 more recent notices · 5 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Oct 14, 26Sell$13KMark HopmanChief Commercial Officer↗
  • Oct 1, 26Sell$7KMark HopmanChief Commercial Officer↗
  • Sep 22, 26Sell$148KChristy Jones↗
  • Sep 16, 26Sell$620KMark HopmanChief Commercial Officer↗
  • Sep 16, 26Sell$58KMike MensingerChief Product Officer↗
  • Sep 14, 26Sell$12KMark HopmanChief Commercial Officer↗
  • Sep 9, 26Sell$665KMark HopmanChief Commercial Officer↗
  • Sep 3, 26Sell$113KSean SaintPresident & CEO↗
  • Sep 2, 26Sell$102KMark HopmanChief Commercial Officer↗
  • Sep 2, 26Sell$84KMike MensingerChief Product Officer↗
  • Sep 2, 26Sell$128KStephen FeiderChief Financial Officer↗
  • Sep 2, 26Sell$322KSean SaintPresident & CEO↗

There are 20 more transactions in this stretch.

Stock compensation, tax and giftsshow the 8 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jun 29, 26Compensation$25KStephen FeiderChief Financial Officer↗
  • Jun 26, 26Compensation$26KStephen FeiderChief Financial Officer↗
  • May 21, 26Compensationamount n/aGERARD J MICHEL↗
  • May 21, 26Compensationamount n/aSEAN CARNEY↗
  • May 21, 26Compensationamount n/aDanny L. Dearen↗
  • May 21, 26Compensationamount n/aMaria Palasis↗
  • May 21, 26Compensationamount n/aAdam Lezack↗
  • May 21, 26Compensationamount n/aChristy Jones↗

The full record holds 129 transactions and goes back to Jan 29, 25.

Its sector and its market

Beta Bionics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Beta Bionics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Beta Bionics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
241 documents on file, from Oct 10, 2024 to Oct 16, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.